Suppr超能文献

新型冠状病毒肺炎合并胸腔积液:临床及预后意义——一项观察性、回顾性研究

Pleural Effusion in COVID-19 Pneumonia: Clinical and Prognostic Implications-An Observational, Retrospective Study.

作者信息

Cappelli Sara, Casto Elisabetta, Lomi Marta, Pagano Alessandra, Gabbrielli Luciano, Pancani Roberta, Aquilini Ferruccio, Gemignani Giulia, Carrozzi Laura, Celi Alessandro

机构信息

Department of Surgical, Medical and Molecular Pathology and Critical Care, University of Pisa, 56126 Pisa, Italy.

Pneumology Unit, Pisa University Hospital, 56126 Pisa, Italy.

出版信息

J Clin Med. 2023 Jan 29;12(3):1049. doi: 10.3390/jcm12031049.

Abstract

BACKGROUND

COVID-19 presents with a wide spectrum of clinical and radiological manifestations, including pleural effusion. The prevalence and prognostic impact of pleural effusion are still not entirely clear.

PATIENTS AND METHODS

This is a retrospective, single-center study including a population of consecutive patients admitted to the University Hospital of Cisanello (Pisa) from March 2020 to January 2021 with a positive SARS-CoV-2 nasopharyngeal swab and SARS-CoV-2-related pneumonia. The patients were divided into two populations based on the presence ( = 150) or absence ( = 515) of pleural effusion on chest CT scan, excluding patients with pre-existing pleural effusion. We collected laboratory data (hemoglobin, leukocytes, platelets, C-reactive protein, procalcitonin), worst PaO/FiO ratio as an index of respiratory gas exchange impairment, the extent of interstitial involvement related to SARS-CoV-2 pneumonia and data on intensity of care, length of stay and outcome (discharge or death).

RESULTS

The prevalence of pleural effusion was 23%. Patients with pleural effusion showed worse gas exchange ( < 0.001), longer average hospital stay ( < 0.001), need for more health care resources ( < 0.001) and higher mortality ( < 0.001) compared to patients without pleural effusion. By multivariate analysis, pleural effusion was found to be an independent negative prognostic factor compared with other variables such as increased C-reactive protein, greater extent of pneumonia and older age. Pleural effusion was present at the first CT scan in most patients (68%).

CONCLUSIONS

Pleural effusion associated with SARS-CoV-2 pneumonia is a relatively frequent finding that is confirmed to be a negative prognostic factor. Identifying early prognostic factors in an endemic-prone disease such as COVID-19 is necessary to optimize its clinical management. Further clinical studies aimed at better characterizing pleural effusion in these patients will be appropriate in order to clarify its pathogenetic role.

摘要

背景

新型冠状病毒肺炎(COVID-19)具有广泛的临床和影像学表现,包括胸腔积液。胸腔积液的患病率及其对预后的影响仍不完全清楚。

患者与方法

这是一项回顾性单中心研究,纳入了2020年3月至2021年1月期间连续入住奇萨内洛大学医院(比萨)的患者,这些患者严重急性呼吸综合征冠状病毒2(SARS-CoV-2)鼻咽拭子检测呈阳性且患有SARS-CoV-2相关肺炎。根据胸部CT扫描有无胸腔积液(有胸腔积液者n = 150,无胸腔积液者n = 515)将患者分为两组,排除既往有胸腔积液的患者。我们收集了实验室数据(血红蛋白、白细胞、血小板、C反应蛋白、降钙素原)、作为呼吸气体交换受损指标的最差动脉血氧分压/吸入氧分数值(PaO₂/FiO₂)、与SARS-CoV-2肺炎相关的间质受累程度以及重症监护强度、住院时间和结局(出院或死亡)的数据。

结果

胸腔积液的患病率为23%。与无胸腔积液的患者相比,有胸腔积液的患者气体交换情况更差(P < 0.001),平均住院时间更长(P < 0.001),需要更多的医疗资源(P < 0.001),死亡率更高(P < 0.001)。通过多因素分析发现,与C反应蛋白升高、肺炎范围更大和年龄较大等其他变量相比,胸腔积液是一个独立的不良预后因素。大多数患者(68%)在首次CT扫描时就出现了胸腔积液。

结论

与SARS-CoV-2肺炎相关的胸腔积液是一种相对常见的表现,且被证实是一个不良预后因素。在COVID-19这种易于流行的疾病中识别早期预后因素对于优化其临床管理很有必要。开展进一步的临床研究以更好地描述这些患者的胸腔积液特征,将有助于阐明其发病机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acd9/9917650/784bfbc10f09/jcm-12-01049-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验